Basic Information
ID: ALA3281976
Type: Functional
Description: Antiviral activity against Encephalomyocarditis virus infected in CF-1 mouse assessed as host survival time ratio at 250 mg/kg, po administered via gavage as single dose at 22 to 28 hrs before virus inoculation
Organism: Encephalomyocarditis virus
Activity Charts
Bioactivity
Activity Types for Assay ALA3281976
Ratio
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 537.66 | 4.86 | 4.86 |
| 538.18 | 6.71 | 6.71 |
| 518.10 | 5.10 | 5.10 |
| 546.15 | 5.59 | 5.59 |
| 462.08 | 5.26 | 5.26 |
| 486.10 | 5.54 | 5.54 |
| 453.58 | 3.24 | 3.24 |
| 434.02 | 4.48 | 4.48 |
| 473.66 | 6.22 | 6.22 |
| 486.19 | 7.14 | 7.14 |
| 491.03 | 4.58 | 4.58 |
| 462.97 | 3.80 | 3.80 |
| 543.10 | 5.65 | 5.65 |
| 515.05 | 5.28 | 5.28 |
| 435.01 | 5.03 | 5.03 |
| 454.66 | 6.58 | 6.58 |
| 430.98 | 4.54 | 4.54 |
| 459.03 | 5.32 | 5.32 |
| 562.62 | 4.24 | 4.24 |
| 406.95 | 4.25 | 4.25 |
| 426.60 | 5.81 | 5.81 |
| 487.08 | 6.10 | 6.10 |
| 435.01 | 4.74 | 4.74 |
| 374.87 | 3.07 | 3.07 |
| 430.98 | 4.64 | 4.64 |
| 455.00 | 4.92 | 4.92 |
| 474.65 | 6.48 | 6.48 |
| 502.70 | 6.98 | 6.98 |
| 691.36 | 9.42 | 9.42 |
| 478.59 | 4.18 | 4.18 |
| 647.37 | 8.95 | 8.95 |
| 394.97 | 3.94 | 3.94 |
| 530.69 | 5.50 | 5.50 |
| 507.18 | 7.05 | 7.05 |
| 475.10 | 5.78 | 5.78 |
| 591.35 | 9.40 | 9.40 |
| 503.15 | 6.56 | 6.56 |
| 451.08 | 5.21 | 5.21 |
| 390.94 | 3.54 | 3.54 |
| 447.04 | 5.10 | 5.10 |
| 490.71 | 6.95 | 6.95 |
| 490.71 | 6.95 | 6.95 |
| 518.77 | 7.44 | 7.44 |
| 531.12 | 4.64 | 4.64 |